Hmmmm... Now here's a good candidate for a future partner...
///
DANBURY, Conn., Nov. 4 /PRNewswire/ -- Trex Medical Corporation
(Amex: TXM) today reported that net income for the year ended September 27,
1997, rose 57 percent to $14,674,000 on revenues of $229,294,000, compared
with net income of $9,344,000 on revenues of $150,195,000 for 1996. Earnings
per share rose 28 percent in 1997 to $.51, compared with $.40 in 1996.
"I'm pleased with the progress we've made in bringing XRE and Continental,
acquired in fiscal 1996, under the Trex Medical umbrella," said Hal Kirshner,
president and chief executive officer of Trex Medical. "And through the
agreements we signed this year with several of the nation's largest hospital
buying groups, we believe we are well-positioned to capture market share and
recognition as one of the top manufacturers of diagnostic imaging systems
incorporating the latest technology."
Trex Medical Corporation is the world's leading manufacturer of
mammography equipment and minimally invasive digital breast-biopsy systems.
In addition, the company manufactures general-purpose X-ray systems and state-
of-the-art imaging systems used during vascular and interventional cardiac
procedures such as balloon angioplasty. Trex Medical is a public subsidiary
of ThermoTrex Corporation (AMEX: TKN), a Thermo Electron (NYSE: TMO) company.
More information is available on the Internet at
thermo.com
///
Regards,
Warren |
